Ryan Savitz

EVP, CFO & Cbo, Dianthus Therapeutics, Inc. /DE/

Bought, 12 months

$0.0M

Sold, 12 months

$14.3M

Companies

Latest trade

Jul 9, 2026

Companies

Dianthus Therapeutics, Inc. /DE/EVP, CFO & Cbo −$14.3M

Trades

DNTH Sold 31,249 shares at $101.03 · planned $3.2M Jul 9

DNTH Sold 8,224 shares at $89.84 · planned $0.7M Apr 9

DNTH Sold 114,367 shares at $83.00 · planned $9.5M Mar 31

DNTH Sold 20,000 shares at $45.18 · planned $0.9M Dec 4

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.